Cargando…

Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease

In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitutio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jen-Shih, Lee, Lian-Pin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159995/
https://www.ncbi.nlm.nih.gov/pubmed/35662845
http://dx.doi.org/10.3389/fbioe.2022.836990
_version_ 1784719179699453952
author Lee, Jen-Shih
Lee, Lian-Pin
author_facet Lee, Jen-Shih
Lee, Lian-Pin
author_sort Lee, Jen-Shih
collection PubMed
description In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitution volume, and plasma volume are changing over the time course of 240 min hemodialysis. For patients with the filtration coefficient KSo as 0.43 or 5.88 ml/min/mmHg, we find that the restitution rate would reach 50% of the extraction rate in 5.3 or 57.4 min, respectively. By the end of hemodialysis, the restitution rate of both patients asymptotically approaches a value of 0.93 ml/min which is slightly higher than the extraction rate of 9.03 ml/min. The plasma volume drops by 10% of the total plasma volume in 11 min for patients with low KSo and drops by 2.1% and turns around to an increasing trend in 5.6 min for patients with high KSo. These results suggest that the filtration coefficient acts like a facilitator in restituting more fluid from the tissue to compensate for the loss of plasma volume due to extraction. The hematocrit data of three sets of hemodialysis also indicate that significant microvascular blood volume is shifted from small veins toward the venous side of macrocirculation. A better understanding of how the factors examined here cause hypovolemia can be the basis for one to modify the hemodialysis process such that the development of hypovolemia can be avoided over the course of hemodialysis.
format Online
Article
Text
id pubmed-9159995
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91599952022-06-03 Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease Lee, Jen-Shih Lee, Lian-Pin Front Bioeng Biotechnol Bioengineering and Biotechnology In our previous analysis of three sets of hemodialysis studies, we found that patients possessing higher hematocrit have a higher filtration coefficient KSo and more fluid being restituted from the tissue. A new dynamic analysis is developed to reveal how the plasma protein concentration, restitution volume, and plasma volume are changing over the time course of 240 min hemodialysis. For patients with the filtration coefficient KSo as 0.43 or 5.88 ml/min/mmHg, we find that the restitution rate would reach 50% of the extraction rate in 5.3 or 57.4 min, respectively. By the end of hemodialysis, the restitution rate of both patients asymptotically approaches a value of 0.93 ml/min which is slightly higher than the extraction rate of 9.03 ml/min. The plasma volume drops by 10% of the total plasma volume in 11 min for patients with low KSo and drops by 2.1% and turns around to an increasing trend in 5.6 min for patients with high KSo. These results suggest that the filtration coefficient acts like a facilitator in restituting more fluid from the tissue to compensate for the loss of plasma volume due to extraction. The hematocrit data of three sets of hemodialysis also indicate that significant microvascular blood volume is shifted from small veins toward the venous side of macrocirculation. A better understanding of how the factors examined here cause hypovolemia can be the basis for one to modify the hemodialysis process such that the development of hypovolemia can be avoided over the course of hemodialysis. Frontiers Media S.A. 2022-05-18 /pmc/articles/PMC9159995/ /pubmed/35662845 http://dx.doi.org/10.3389/fbioe.2022.836990 Text en Copyright © 2022 Lee and Lee. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Lee, Jen-Shih
Lee, Lian-Pin
Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title_full Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title_fullStr Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title_full_unstemmed Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title_short Microvascular Dynamics and Hemodialysis Response of Patients With End-Stage Renal Disease
title_sort microvascular dynamics and hemodialysis response of patients with end-stage renal disease
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159995/
https://www.ncbi.nlm.nih.gov/pubmed/35662845
http://dx.doi.org/10.3389/fbioe.2022.836990
work_keys_str_mv AT leejenshih microvasculardynamicsandhemodialysisresponseofpatientswithendstagerenaldisease
AT leelianpin microvasculardynamicsandhemodialysisresponseofpatientswithendstagerenaldisease